KRONOS® AIR DISINFECTION TECHNOLOGY MANUFACTURER RECEIVES FDA 510(K) CLASS II MEDICAL DEVICE CLEARANCE FOR THE DESTRUCTION OF VIRUSES, BACTERIA, AND ALLERGENS.
FDA Clearance Provided After Review Of Patented Air Disinfection Technology Proven Effective At Eliminating Harmful Airborne particles.
Parkersburg, WV, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Parkersburg, WV January 10, 2023 /Globenewswire/ KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) ("KNOS" or the "Company"), innovation-driven product development and creator of patented Kronos® CORE air disinfection technology inside its advanced smart air purification devices, announced today that the U.S. Food and Drug Administration (FDA) has recently granted 510(k) clearance, classifying it as a Class II Medical Device. The FDA clearance was provided to the product manufacturer after a detailed review of the patented Model 5 device, which utilizes patented High Voltage Field air disinfection technology and is proven to eliminate 99.9% of harmful airborne particles, including allergens, bacteria, fungi, and viruses, like COVID-19. FDA Clearance which means our air purifiers can be deployed in hospitals and home health-care settings to clear the air of infected bioaerosol droplets , in addition, our products comply with all CARB regulations related to air cleaners for sale in California, and the Company’s manufacturer is registered with the State of California CARB.
Kronos can now provide schools, healthcare facilities, businesses, hotels, and government agencies with the best medical-grade air purification and air disinfection technology.
“We are proud that our manufacturer has been granted FDA clearance for the Model 5 Air Purifier, and we want to thank the FDA Team for their investigation and test results review of Kronos CORE patented air disinfection technology,” said Michael Rubinov, CEO of Kronos. “We have been developing air disinfection and purification technology since 2002 and we are experts in Indoor Air Quality. The recently approved FDA clearance of the Model 5 device, which is powered by our patented Kronos® air disinfection technology, represents a major step forward to marketing our products to hospitals, doctors’ offices, allergy suffers and areas where natural disasters occurred like when wildfires happen.” – added Michael Rubinov, CEO of Kronos.
“There are only a few air purifier manufacturers on the market today that has received 501(k) clearance, and this marks a significant milestone for our company and our shareholders. This certification validates the performance of the Kronos Model 5 air disinfection technology capabilities, as we are getting ready to manufacture our innovative products domestically at our new manufacturing facility and move to dominate the air purification industry.”- commented Joseph Florence, COO of Kronos.
The Model 5, which is the most popular model, has been rigorously tested in several credible international testing labs. Kronos® developed technology is an active filtration technology. Unlike other solutions- It generates a high voltage electric field to electrify and destroy harmful particles and collects them on the easy-to-wash uniquely designed collecting plates. Its 3 layers of washable filter technology equate to zero dollars in maintenance costs while eliminating up to 99.9% of Harmful Particles, 99.9% of PM 2.5, and 99% of Chemical Toxins in the air it cleans.
Traditional HEPA filter-based air filtration systems only capture larger particles such as dust or pet hair and require frequent filter changes to maintain effectiveness, drastically increasing system maintenance costs. Our technology has the ability to remove contaminants and allergens down to 14.6 nanometers (.0146 microns) which is 20 times smaller than HEPA filters – a definite market advantage.
As reported recently by CNN: Omicron offshoot XBB.1.5 could drive a new Covid-19 surge in the US. The CDC estimates that XBB.1.5 has more than doubled its share of the Covid-19 pie each week for the last four, rising from about 4% to 41% of new infections over December. In the Northeast, the CDC estimates XBB.1.5 is causing 75% of new cases. Americans have been slow to get the new boosters, however. According to CDC data, only 15% of Americans who are eligible have had an updated booster. Among seniors – those age 65 and older – only about 1 in 3 have had an updated shot.
Experts also note that although antibody treatments won’t work against this sublineage, other antivirals, such as Paxlovid and Remdesivir, should still be effective.
Rapid tests continue to work, as do masks, and ventilation and filtration of indoor air, so even as the virus continues to evolve, there are still good ways to protect yourself from getting Covid-19.
“For a few months now, we haven’t seen a variant that’s taken off at that speed,” said Pavitra Roychoudhury, director of Covid-19 sequencing at the University of Washington School of Medicine’s virology lab.
KNOS is committed to helping our customers, businesses, and government offices improve Indoor Air Quality (IAQ) and to provide healthier and safer air.
